ICICI Securities Ltd | Retail Equity Research Revenues declined 13% YoY to | 879 crore (I-direct estimate: | 817 crore) mainly on account of higher base of gAbilify in Q2FY16. Export sales declined 38% to | 352 crore, higher than I-direct estimate of | 313 crore. Domestic branded formulation sales grew 19% to | 338 crore (I-direct estimates: | 336 crore) on account of 22% growth in the acute portfolio and 16% growth in the speciality portfolio EBITDA margins were at 20.2% (I-direct estimate: 20.0%) vs. 37.3%...